IP Library Granted Patent US 7,332,354
Granted Patent B2
US 7,332,354 · App. 10/479,320 · Granted Feb 19, 2008

Compounds for chemiluminescense procedures

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,332,354
App. No.
10/479,320
Granted
Feb 19, 2008
Kind
B2
Abstract

The present invention relates to a chemical compound comprising a light emitting moiety precursor and a precursor of a leaving group, bound to each other by an amide or by an ester bond and characterized in that the leaving group precursor upon oxidation is converted into the leaving group. The invention also relates to compounds additionally comprising a coupling group to the use of such compounds for labeling of biomolecules and more generally to the use of such compounds in chemiluminescence detection procedures.

Claims (4)

1. A chemical compound comprising a light emitting moiety precursor selected from the group consisting of 2-(4 hydroxyphenyl) 4H benzo[e][1,3] oxazine-4-carboxylic acid, 2-(4-hydroxyphenyl) 4,5 dihydro thiazole 5,5 dimethyl-4-carboxylic acid, luciferin and acridinium-9-carboxylic acid and a leaving group precursor selected from the group consisting of leuko-resorufin and leuko-oxazine, wherein the carbonyl group of the light emitting precursor is linked via an amide bond to a nitrogen atom of the leaving group precursor and wherein said nitrogen atom of the leaving group precursor is an oxidizable nitrogen and part of a donor-pi-donor redox system.

2. The compound of claim 1 wherein the light emitting moiety precursor is luciferin.

3. The compound of claim 1 , wherein the leaving group precursor further comprises a coupling group.

4. A conjugate comprising a biomolecule selected from the group consisting of polypeptides, nucleic acids, and drugs and a compound according to claim 1 wherein the biomolecule is linked to the compound via the coupling group.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2004
From: ROCHE DIAGNOSTICS CORPORATION
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 015201/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2004
From: HEINDL, DIETER; HERRMANN, RUPERT; JOSEL, HANS-PETER; HUBER, ERASMUS; KLAUSE, URSULA
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 015294/0627 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2004
From: ROCHE DIAGNOSTICS GMBH
To: ROCHE DIAGNOSTICS CORPORATION
Reel/Frame 015294/0675 →